Last reviewed · How we verify

NCT03550924

Transnasal Humidified Rapid Insufflation Ventilatory Exchange in Morbidly Obese

Completed NA Last updated 2 September 2020
What this trial tests

NA trial testing low flow passive oxygenation in Anesthesia Intubation Complication in 40 participants. Completed in 22 January 2020.

Timeline
26 July 2018
Primary endpoint
22 January 2020
22 January 2020

Quick facts

Lead sponsorMedical University of Vienna
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date26 July 2018
Primary completion22 January 2020
Estimated completion22 January 2020
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Vienna

Who can join

Adults 19 to 65, any sex, with Anesthesia Intubation Complication or Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will investigate the duration of apnea without desaturation when using transnasal humidified rapid insufflation ventilatory exchange (THRIVE) vs. low flow nasal oxygen at anesthesia induction in obese patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Oxygenation during the apnoeic phase preceding intubation in adults in prehospital, emergency department, intensive care and operating theatre environments.
    White LD, Vlok RA, Thang CY, Tian DH, et al · · 2023 · cited 6× · PMID 37531462 · DOI 10.1002/14651858.cd013558.pub2

Verify or expand the search:

Other recruiting trials for Anesthesia Intubation Complication

Currently open trials in the same condition.

Other Medical University of Vienna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03550924.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing